Definitive Healthcare Corp. (NASDAQ:DH)
| Market Cap | 103.77M-70.0% |
| Revenue (ttm) | 232.70M-5.0% |
| Net Income | -168.20M+44.8% |
| EPS | -1.60+39.6% |
| Shares Out | 105.52M |
| PE Ratio | n/a |
| Forward PE | 5.27 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 917.09 |
| Open | 0.98 |
| Previous Close | 0.97 |
| Day's Range | 0.97 - 0.98 |
| 52-Week Range | 0.61 - 3.31 |
| Beta | 1.40 |
| Analysts | Hold |
| Price Target | 1.20(+22.03%) |
| Earnings Date | Nov 5, 2026 |
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About DH
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
$DH stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in DH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by DH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
DH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
DH Revenue by Segment or Geography
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New DH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to DH from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in DH
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.26M |
| DFASDimensional - US Small Cap ETF | $627.36K |
| VXFVanguard Extended Market ETF | $453.78K |
| DFMCU.S. Micro Cap Portfolio ETF | $271.53K |
| DFACDimensional - US Core Equity 2 ETF | $201.85K |
| IWCiShares Micro-Cap ETF | $114.50K |
Estimated from each fund’s disclosed top holdings × AUM
DH Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from DH’s recent data — informational, not investment advice
